Naoki Okamura, Astellas CEO (Toru Hanai/Bloomberg via Getty Images)
Astellas places new bet on gene therapy in $50M upfront deal with UK startup
As it works to rebuild from an earlier gene therapy setback, Astellas is doubling down on the one-and-done modality in a new deal with a …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
